Lack of information and access to advanced treatment for Parkinson’s disease patients

J Lökk1 Department of Neurobiology, Caring Sciences and Society, The Karolinska Institute, Stockholm, Sweden;2 Karolinska University Hospital Huddinge, Stockholm, SwedenCorrespondence[email protected]

Pages 433-439 | Published online: 13 Dec 2011

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MaetzlerWLiepeltIBergDProgression of Parkinson’s disease in the clinical phase: potential markersLancet Neurol20098121158117119909914
PubMed Web of Science ®Google Scholar
SanyalJChakrabortyDPSarkarBEnvironmental and familial risk factors of Parkinsons disease: case-control studyCan J Neurol Sci201037563764221059511
PubMed Web of Science ®Google Scholar
JancovicJKapadiaASFunctional decline in Parkinson’s diseaseArch Neurol200158101611161511594919
PubMedGoogle Scholar
RosaMMFerreiraJJCoelhoMFreireRSampaioCPrescribing pattern of antiparkinsonian agents in EuropeMov Disord20102581053106020222132
PubMed Web of Science ®Google Scholar
RytonBALiddleBJImplementing NICE clinical guidelines on Parkinson’s diseaseClin Med20099543644019886102
PubMed Web of Science ®Google Scholar
AlvesGWentzel-LarsenTAarslandDLarsenJPProgression of motor impairment and disability in Parkinson’s disease: a population-based studyNeurology20056591436144116275832
PubMed Web of Science ®Google Scholar
ChaudhuriKRShapiraAHNon-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatmentLancet Neurol20098546447419375664
PubMed Web of Science ®Google Scholar
OkunMSFooteKDParkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targetsExpert Rev Neurother201010121847185721384698
PubMed Web of Science ®Google Scholar
StocchiFUse of apomorphine in Parkinson’s diseaseNeurol Sci200829Suppl 5S383S38619381769
PubMed Web of Science ®Google Scholar
FernandezHHOdinPLevodopa-carbidopa intestinal gel for treatment of advanced Parkinson’s diseaseCurr Med Res Opin201127590791921351823
PubMed Web of Science ®Google Scholar
ScottBNyholmDPatient-perceived retrospective outcome of duodenal levodopa infusion in advanced Parkinson’s DiseaseEur Neurol J20102310
Google Scholar
DowdingCHShentonCLSalekSSA review of the health-related quality of life and economic impact of Parkinson’s diseaseDrugs Aging200623969372117020395
PubMed Web of Science ®Google Scholar
LökkJBorgSSvenssonJPerssonULjunggrenGDrug and treatment costs in Parkinson’s disease patients in SwedenActa Neurol Scand462011 [Epub ahead of print.]
Web of Science ®Google Scholar
LökkJCaregiver strain in Parkinson’s disease and the impact of disease durationEur J Phys Rehabil Med2008441394518385627
PubMed Web of Science ®Google Scholar
PandyaMKubuCSGirouxMLParkinson’s disease: not just a movement disorderCleve Clin J Med2008751285686419088004
PubMed Web of Science ®Google Scholar
PetersMFitzpatrickRDollHPlayfordDJenkinsonCDoes selfreported well-being of patients with Parkinson’s disease influence caregiver strain and quality of life?Parkinsonism Relat Disord201117534835221356603
PubMed Web of Science ®Google Scholar
NyholmDLewanderTJohanssonALewittPALundqvistCAquiloniusSMEnteral levodopa/carbidopa infusion in advanced Parkinson’s disease: long-term exposureClin Neuropharmacol2008312637318382177
PubMed Web of Science ®Google Scholar
AntoniniAOdinPPros and cons of apomorphine and L-dopa continuous infusion in advanced Parkinson’s diseaseParkinsonism Relat Disord200915Suppl 4S97S10020123567
PubMed Web of Science ®Google Scholar
ClarkeCEWorthPGrossetDStewartDSystematic review of apomorpine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson’s diseaseParkinsonism Relat Disord2009151072874119805000
PubMed Web of Science ®Google Scholar
WeaverFMFollettKSternMCSP 468 Study GroupBilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trialJAMA20093011637319126811
PubMed Web of Science ®Google Scholar
PolettiMEmreMBonuccelliUMild cognitive impairment and cognitive reserve in Parkinson’s diseaseParkinsonism Relat Disord201117857958621489852
PubMed Web of Science ®Google Scholar
HilkerRAntoniniAOdinPWhat is the best treatment for fluctuating Parkinson’s disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?J Neural Transm2011118690791421188435
PubMed Web of Science ®Google Scholar
GallagheerDASchragAImpact of newer pharmacological treatments on quality of life in patients with Parkinson’s diseaseCNS Drugs200822756358618547126
PubMed Web of Science ®Google Scholar
SmitsQAAndsbergGAndersenPMAndressonMFredrikssonSGunnarssonMNeurology in transition from diagnostic to therapeutic discipline. (Swedish: Neurologi i förvandling – från diagnostisk till terapeutisk disciplin)Läkartidningen20101053624132416
Google Scholar
MüllerTWoitallaDQuality of life, caregiver burden and insurance in patients with Parkinson’s disease in GermanyEur J Neurol201017111365136920443985
PubMed Web of Science ®Google Scholar
OlanowCWHauserRAJankovicJA randomized, doubleblind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson’s disease (the ADAGIO study): rationale, design, and baseline characteristicsMov Disord200823152194220118932271
PubMed Web of Science ®Google Scholar
LökkJNilssonMFrequency, type and factors associated with the use of complementary and alternative medicine in patients with Parkinson’s disease at a neurological outpatient clinicParkinsonism Relat Disord201016854054420655794
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Lack of information and access to advanced treatment for Parkinson’s disease patients

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Lack of information and access to advanced treatment for Parkinson’s disease patients

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date